GeneSeeq Raises "Hundred of Millions Of RMB" In C Round To Develop NGS
Published: Jul 24, 2017
July 21, 2017 -- Geneseeq, a Nanjing-Toronto genetic sequencing company, closed a C funding round of "hundreds of millions of RMB," according to the company. Founded in 2008, Geneseeq focuses on genetic sequencing to provide personalized medicine for tumor related diseases. The company has a pan-genomic testing system that detects genetic abnormalities in 416 cancer-related genes. Each 100 million RMB would be worth $15 million, implying the funding totaled at least $30 million.